These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3246814)

  • 1. [Prognostic evaluation of prostatic cancer by Gleason's histopathologic grading and tissue DHT level].
    Kohama Y; Morioka M; Kamei Y; Yamamoto Y; Sen Y; Fujita Y; Sonobe H
    Nihon Hinyokika Gakkai Zasshi; 1988 Jul; 79(7):1228-34. PubMed ID: 3246814
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S
    Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with Gleason's histopathologic grading in prostatic cancer.
    Kramer SA; Spahr J; Brendler CB; Glenn JF; Paulson DF
    J Urol; 1980 Aug; 124(2):223-5. PubMed ID: 6995622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification].
    Uchida T; Go M; Nakajo H; Takagi Y; Murayama M; Honda N; Igarashi M; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1988 Jan; 34(1):116-22. PubMed ID: 3376792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHT in prostate cancer tissue--a guide to management and therapy.
    Geller J; Albert JD
    Prostate; 1985; 6(1):19-25. PubMed ID: 3969370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gleason's histologic grading as clinical prognostic marker in patients with advanced prostatic carcinoma.
    Schwartz CB; Bekirov H; Melman A
    Urology; 1991 Mar; 37(3):198-201. PubMed ID: 2000673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
    Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrotestosterone measured in core biopsies from prostatic tissues.
    Bruun E; Frandsen H; Nielsen K; Rasmussen LB; Vinnergaard T; Frimodt-Møller C
    Am J Clin Oncol; 1988; 11 Suppl 2():S27-9. PubMed ID: 2468272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy.
    Geller J; Albert JD; Nachtsheim DA; Loza D
    J Urol; 1984 Oct; 132(4):693-6. PubMed ID: 6471215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal therapy of advanced prostatic cancer.
    Fair WR
    J Urol; 1986 Sep; 136(3):653-4. PubMed ID: 2942708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multivariate analysis of prognostic factors in patients with prostatic cancer].
    Miyamoto T; Yuasa M; Furukawa A; Tamura M; Kawanishi Y; Numata A; Imagawa A; Kagawa S
    Hinyokika Kiyo; 1991 Dec; 37(12):1663-8. PubMed ID: 1785390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The usefulness of hormonal therapy in the treatment of prostatic cancer--clinical analysis of 160 cases over 12 years in the single institute].
    Hayakawa K; Kimura S; Ikeuchi K
    Nihon Hinyokika Gakkai Zasshi; 1994 Aug; 85(8):1256-62. PubMed ID: 7933760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer. Endocrine and cytotoxic therapy.
    Smith PH
    Recent Results Cancer Res; 1981; 78():154-72. PubMed ID: 7022593
    [No Abstract]   [Full Text] [Related]  

  • 17. DHT concentrations in human prostate cancer tissue.
    Geller J; Albert J; Loza D; Geller S; Stoeltzing W; de la Vega D
    J Clin Endocrinol Metab; 1978 Mar; 46(3):440-4. PubMed ID: 87401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Ohshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):275-84. PubMed ID: 2191569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ; Pavone-Macaluso M; Smith PH; de Pauw M; Suciu S
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endocrinologic therapy of prostatic cancer].
    Nihira H
    Nihon Hinyokika Gakkai Zasshi; 1986 Dec; 77(12):1910-4. PubMed ID: 3586440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.